Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Menoforce is a herbal medicinal product developed by A. Vogel AG, containing a concentrated extract of fresh sage (*Salvia officinalis*) leaves. It is specifically indicated for the relief of excessive sweating (hyperhidrosis) and hot flushes associated with menopause. Unlike traditional hormone replacement therapies, Menoforce is thought to exert its effects by stabilizing the thermoregulatory center in the hypothalamus rather than through direct systemic estrogenic activity. Clinical data, including Phase 4 studies, have demonstrated that a once-daily dose of the 3400 mg equivalent extract significantly reduces the frequency and intensity of vasomotor symptoms in menopausal women. The preparation is standardized to ensure consistent levels of active constituents, such as essential oils and phenolic acids, while maintaining a safety profile suitable for long-term use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Menoforce.